TET2 and breast cancer: Over-expression of TET2 Catalytic Domain (TET2-CD) increases the 5hmC levels, which induces and inhibits the expression of thousands of genes that inhibit cell proliferation and migration in MCF-7 BC cells, as well as tumor growth in vivo.